Patrick A. Kenney, MD
Assoc Dean for Clinical Affairs and Chief Ambulatory Physician ExecutiveCards
About
Titles
Assoc Dean for Clinical Affairs and Chief Ambulatory Physician Executive
Biography
- Clinical interests: Localized, locally advanced and metastatic kidney cancer. Robotic surgery for kidney masses and kidney cancer. Robotic partial and radical nephrectomy, including robotic IVC tumor thrombectomy. Complex partial and radical nephrectomy. Caval tumor thrombectomy. Cytoreductive nephrectomy. Retroperitoneal lymphadenectomy. Renal Cell Carcinoma.
Patrick Kenney, MD is a urologic oncologist who cares for patients with cancers of the kidney. He performs robotic and open surgery for kidney cancer, with an emphasis on organ/function preservation and minimally invasive surgery whenever feasible. He is interested in the integration of surgery and systemic therapy for locally advanced, metastatic, and treatment-resistant kidney cancer.
In his clinical practice, Dr. Kenney emphasizes the importance of the doctor-patient relationship. Dr. Kenney believes in the importance of effective communication with patients, family and referring physicians. He strives to treat his patients with compassion and respect. Dr. Kenney believes that the seamless integration of Smilow Cancer Hospital and Yale New Haven Hospital, a full service academic general hospital, affords his patients an outstanding opportunity to receive the highest quality multidisciplinary care.
In addition, Dr. Kenney has an active administrative role in the Yale New Haven Health System and Yale Medicine, having previously served as Interim Chair of the Department of Urology, Clinical Leader for Genitourinary Oncology at Smilow Cancer Hospital, Clinical Vice Chair of Yale Medicine Urology, Vice Chair of Quality and Safety of Yale Medicine Urology, as well as Medical Director of Corporate Supply Chain for Yale New Haven Health System and Medical Director of the Smilow Cancer Hospital Care Center at Greenwich Hospital. Currently, Dr. Kenney is the Chief Ambulatory Physician Executive and Associate Dean of Clinical Affairs.
Dr. Kenney received his MD from Columbia University, where he was elected to the Alpha Omega Alpha Honor Medical Society. Dr. Kenney was also inducted to the Gold Humanism Honor Society in recognition of excellence in clinical care, leadership, compassion and dedication to patient service. Dr. Kenney completed a general surgery internship and urology residency at Lahey Clinic in Massachusetts followed by a Fellowship in Urologic Oncology at MD Anderson Cancer Center in Houston, TX.
Dr. Kenney is active in research and has authored chapters and reviews with a particular emphasis on kidney cancer, kidney surgery, and health services and outcomes. He has presented his work at regional, national, and international meetings. He is a member of the American Urologic Association and the American Society of Clinical Oncology.
Appointments
Urology
Associate Professor on TermPrimary
Other Departments & Organizations
- Developmental Therapeutics
- Prostate & Urologic Cancers Program
- Robotic Surgery and Laparoscopy
- Urologic Oncology
- Urology
- Yale Cancer Center
- Yale Medicine
- Yale Ventures
Education & Training
- Fellowship
- MD Anderson Cancer Center (2013)
- Residency
- Lahey Clinic Medical Center (2011)
- Residency
- Lahey Clinic Medical Center (2007)
- Internship
- Lahey Clinic Medical Center (2006)
- MD
- Columbia University Coll of Physicians & Surgeons (2005)
- Post Graduate
- Premedical Studies (2000)
- BA
- University of Notre Dame (1997)
Research
Overview
Medical Research Interests
Publications
2024
Management strategies for radio-recurrent prostate cancer: a comprehensive review
Rahman S, Kim H, Webb L, Diaz G, Leapman M, Sprenkle P, Brito J, Renzulli J, Martin T, Kenney P, Kim I. Management strategies for radio-recurrent prostate cancer: a comprehensive review. Translational Cancer Research 2024, 0: 0-0. PMID: 39697737, PMCID: PMC11651831, DOI: 10.21037/tcr-24-245.Peer-Reviewed Original Research
2023
Implementation of a health system intervention to reduce time from presentation to surgical intervention for pediatric testicular torsion
Heckscher D, Jalfon M, Buck M, Abello A, Nguyen J, Casilla-Lennon M, Leapman M, Hittelman A, Teitelbaum J, Emerson B, Kenney P, Cavallo J, Lambert S. Implementation of a health system intervention to reduce time from presentation to surgical intervention for pediatric testicular torsion. Journal Of Pediatric Urology 2023, 20: 254.e1-254.e7. PMID: 38030428, DOI: 10.1016/j.jpurol.2023.10.042.Peer-Reviewed Original Research
2022
Association Between Private Equity Acquisition of Urology Practices and Physician Medicare Payments
Nie J, Hsiang W, Lokeshwar SD, McMahon G, Demkowicz PC, Kenney PA, Breyer BN, Leapman MS. Association Between Private Equity Acquisition of Urology Practices and Physician Medicare Payments. Urology 2022, 167: 121-127. PMID: 35680053, DOI: 10.1016/j.urology.2022.03.045.Peer-Reviewed Original ResearchVesical clear cell adenocarcinoma of Müllerian origin treated conservatively with partial cystectomy
Harold JA, Casilla-Lennon M, Kenney PA, Ratner ES. Vesical clear cell adenocarcinoma of Müllerian origin treated conservatively with partial cystectomy. BMJ Case Reports 2022, 15: e245015. PMID: 35383096, PMCID: PMC8984011, DOI: 10.1136/bcr-2021-245015.Peer-Reviewed Original ResearchConceptsClear cell adenocarcinomaPartial cystectomyCell adenocarcinomaMüllerian originPAX-8 stainingExtensive endometriosisAdjuvant therapyFinal pathologyTotal hysterectomyTransurethral resectionBladder massResidual tumorCystectomyAdenocarcinomaHysterectomyEndometriosisResectionTherapyTumorsPathologyWomen
2021
Cachexia and bladder cancer: clinical impact and management
Lokeshwar SD, Press BH, Nie J, Klaassen Z, Kenney PA, Leapman MS. Cachexia and bladder cancer: clinical impact and management. Current Opinion In Supportive And Palliative Care 2021, 15: 260-265. PMID: 34698663, DOI: 10.1097/spc.0000000000000580.Peer-Reviewed Original ResearchConceptsRadical cystectomyBladder cancerPharmacological agentsManagement of cachexiaNovel pharmaceutical agentsPostoperative complicationsWorse survivalMultidisciplinary managementClinical outcomesHypercatabolic statePalliative carePoor outcomeClinical trialsNutritional supplementationBCa patientsClinical impactPhysical therapyCachexiaRadiation therapyHuman studiesPatientsTherapeutic outcomesNutritional deficienciesNutritional supplementsTumor microenvironmentUrology Practice Acquisitions by Private Equity Firms from 2011–2021
Nie J, Demkowicz P, Hsiang W, Umer W, Chen E, McMahon G, Kenney P, Breyer B, Parikh R, Leapman M. Urology Practice Acquisitions by Private Equity Firms from 2011–2021. Urology Practice 2021, 9: 17-24. PMID: 37145557, DOI: 10.1097/upj.0000000000000269.Peer-Reviewed Original ResearchReply by Authors
Nie J, Demkowicz P, Hsiang W, Umer W, Chen E, McMahon G, Kenney P, Breyer B, Parikh R, Leapman M. Reply by Authors. Urology Practice 2021, 9: 24-24. PMID: 37145588, DOI: 10.1097/upj.0000000000000269.02.Peer-Reviewed Original ResearchPD38-10 AN INITIATIVE TO REDUCE DOOR TO INCISION TIME FOR PATIENTS WITH TESTICULAR TORSION
Nguyen J, Buck M, Abello A, Lennon M, Leapman M, Hittelman A, Teitelbaum J, Emerson B, Cavallo J, Kenney P, Lambert S. PD38-10 AN INITIATIVE TO REDUCE DOOR TO INCISION TIME FOR PATIENTS WITH TESTICULAR TORSION. Journal Of Urology 2021, 206: e666-e666. DOI: 10.1097/ju.0000000000002048.10.Peer-Reviewed Original ResearchPD38-07 ANTIBIOTIC PROPHYLAXIS PRIOR TO OUTPATIENT UROLOGIC PROCEDURES: OUTCOMES FROM A DEPARTMENT-WIDE QUALITY IMPROVEMENT PROJECT
Buck M, Nguyen J, Abello A, Leapman M, Cavallo J, Kenney P. PD38-07 ANTIBIOTIC PROPHYLAXIS PRIOR TO OUTPATIENT UROLOGIC PROCEDURES: OUTCOMES FROM A DEPARTMENT-WIDE QUALITY IMPROVEMENT PROJECT. Journal Of Urology 2021, 206: e664-e665. DOI: 10.1097/ju.0000000000002048.07.Peer-Reviewed Original ResearchAccess to Urologic Care at Urgent Care Centers
Hsiang WR, Yousman L, Kim D, Cavallo JA, Kenney PA, Motamedinia P, Breyer B, Leapman MS. Access to Urologic Care at Urgent Care Centers. Urology 2021, 156: 124-128. PMID: 34181971, DOI: 10.1016/j.urology.2021.06.009.Peer-Reviewed Original ResearchConceptsUrgent care centersUrologic careCare centerCommercial insuranceMultivariable logistic regression analysisPrimary study endpointCross-sectional studyFacility-level characteristicsLogistic regression analysisMedicaid expansion statesLogistic regression modelsState Medicaid expansionsStudy endpointMedicaid insuranceCommercial patientsEmergency departmentReferral ratesPatient insuranceMedicaid patientsUrologic conditionsUrologic emergencyGreater oddsPatientsTriage ratesClinical setting
Clinical Trials
Current Trials
Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)
HIC ID2000037155RolePrincipal InvestigatorPrimary Completion Date07/31/2033Recruiting Participants
Academic Achievements & Community Involvement
Clinical Care
Overview
Patrick Kenney, MD, is urologic oncologist with a clinical focus on advanced surgery for Renal Cell Carcinoma, cancer of the kidney. He utilizes both robotic and open surgery, with a particular interest in organ/function preservation and minimally invasive surgery whenever feasible.
Dr. Kenney performs a variety of procedures, including minimally invasive robotic surgery, robotic partial and radical nephrectomy, and complex surgical procedures such as cytoreductive nephrectomy and retroperitoneal lymphadenectomy. He has particular expertise in surgery for venous tumor thrombus, called IVC tumor thrombectomy, which Dr. Kenney performs robotically whenever appropriate. He works closely with partners in medical oncology to integrate surgery with systemic therapy to treat locally advanced, metastatic, and treatment-resistant kidney cancer.
Emphasizing the importance of the doctor-patient relationship, Dr. Kenney prioritizes effective communication with patients, their families, and referring physicians. “Cancer diagnosis and treatment are often harrowing and difficult for patients – accessing world-class care close to home shouldn’t be,” he says. “The opportunity to improve a patient’s quality of life and guide them through some of the most challenging moments of their lives is incredibly rewarding.”
Now serving as Associate Dean for Clinical Affairs at Yale School of Medicine and Chief Ambulatory Physician Executive, Dr. Kenney received his medical degree from Columbia University, where he was elected to the Alpha Omega Alpha Honor Medical Society and inducted into the Gold Humanism Honor Society. He completed a general surgery internship and urology residency at Lahey Clinic Medical Center, followed by a fellowship in Urologic Oncology at MD Anderson Cancer Center.
Active in research, Dr. Kenney has authored chapters and reviews about kidney cancer, kidney surgery, and health services and outcomes. He has presented his work at regional, national, and international meetings and holds memberships in the American Urologic Association and the American Society of Clinical Oncology.
Clinical Specialties
Fact Sheets
Kidney Cancer
Learn More on Yale MedicineDiagnosing Kidney Disease
Learn More on Yale MedicineDiagnosing Lupus Nephritis
Learn More on Yale MedicineJelmyto®
Learn More on Yale Medicine
Board Certifications
Urology
- Certification Organization
- AB of Urology
- Original Certification Date
- 2015
Yale Medicine News
News & Links
News
- January 16, 2025
Yale Urology Research [Q4: October-December 2024]
- November 19, 2024
2nd Annual Yale Urology Bulldog Debates Recap
- June 26, 2024
2024 Yale Urology Graduation Banquet
- May 07, 2024Source: Urology Times
Yale Faculty on Unmet Needs in Kidney Cancer
Get In Touch
Contacts
Urology
PO Box 208058
New Haven, CT 06520-8058
United States
Administrative Support
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.